Fusion Antibodies

United Kingdom
Belfast, Northern Ireland, United Kingdom, BT17 0QL

Company profile

Fusion Antibodies company profile

Fusion Antibodies specializes in production of high quality humanized monoclonal antibodies and antibody engineering projects. The company has the knowledge and expertise to build and deliver a bespoke package of the services people need to achieve outstanding results. Using the technology, the sequences of the antibody variable domains which determine its binding specificity are incorporated into human donor sequences creating a panel of full length humanized antibodies for expression. Fully humanized monoclonal antibodies are an essential step in the progression of your drug to the clinic and the in-house expertise at Fusion Antibodies ensures its success. All of Fusion Antibodies services are offered on a fee-for-service basis and is flexible on the elements of the project people would like included. Fusion Antibodies have strong links with the several partners around the globe, allowing it to deliver a complete bespoke package, at an incredible price. Fusion Antibodies was founded on 2001 and is based in Belfast, United Kingdom.

Business identity

Contact email
[email protected]
Phone number
+44 28 9043 2800
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2001-01-01, Year

Headquarters

Postal code
BT17 0QL
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$4.3M
Last funding
Post IPO Equity / $1.8M / 2024-02-14
Last equity funding
Post IPO Equity / $1.8M
Investors
5
Founders
1
Articles
47
Exited on
2017-12-18

Founders and investors

Founders

Jim Johnston

Investors

Clarendon Fund ManagersCrescent CapitalInvest Northern IrelandQUBISUniversity Challenge Fund